H. Nijman

Cancer Research · 2011–2020

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom H. Nijman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Adrian L. Harris

Papers from H. Nijman's perspective

Ordered by how strongly the researchers H. Nijman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
  2. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
  3. Effector memory T cells, early metastasis, and survival in colorectal cancer. (New England Journal of Medicine)
  4. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. (Immunity)
  5. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (Nature Medicine)
  6. Tertiary lymphoid structures in the era of cancer immunotherapy (Nature Reviews. Cancer)
  7. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. (Journal of Clinical Oncology)
  8. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. (Cancer Research)
  9. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. (New England Journal of Medicine)
  10. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. (Proceedings of the National Academy of Sciences of the United States of America)

Their papers